Sat, Dec 4, 2021
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Healthcare private equity posts highest ever deal value in 2019

Friday, March 13, 2020

Bailey McCann, Opalesque New York:

Healthcare private equity had a robust 2019. Total disclosed deal value reached $78.9 billion, the highest on record, and the deal count of 313 was in line with the 316 deals of 2018, according to new data from Bain and Company.

Healthcare private equity also outperformed all other sectors of private equity activity representing 18% of all disclosed deal value. The most active market was in the US.

Along with deal activity, healthcare exits also posted a banner year. Disclosed deal values rose 29% to $40.8 billion and count rose 13% to 126.

The average deal size rose roughly 25% as funds focused more on larger assets. There were 27 deals greater than $1 billion in value in 2019, compared with 18 such deals in 2018. Biopharma had an exceptional year as disclosed value grew 146% to $40.7 billion. HCIT across sectors also excelled, with value doubling to $17.5 billion.

The increase in deal size represents increased investor confidence in healthcare companies overall. 2019 also saw the largest buyout deal in over a decade with the $10.1 billion acquisition of Nestlé Skin Health by EQT and Abu Dhabi Investment Authority. This deal was especially notable as overall deal size in other sectors has declined as private equity firms face stiffer competition and high valuations.

Looking ahead, Bain & Company expects that deal flow in the healthcare sector will remain strong. Increased worldwide demand for healthcare services was......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. SPACs: Trump-tied SPAC seeks Wall Street support, Nextdoor surges in public market debut after SPAC merger, Barrows Hotel Enterprises considers SPAC merger, Aussie SPAC targets big deal after NASDAQ IPO[more]

    Trump-tied SPAC seeks Wall Street support From Al Jazeera: Day traders and Reddit enthusiasts helped fuel a spectacular rally in Digital World Acquisition Corp shares, which reached a closing high of $94.20 last month before leveling out to recently trade around $60. The blank-ch

  2. Tiger funds change some stripes, Melvin Capital's comeback plan, What's behind Sachem Head's surge?, One of Asia's oldest hedge funds is buying distressed China debt[more]

    Tiger funds change some stripes From Institutional Investor: Falcon Edge, Light Street, Lone Pine, Viking, and Hound made significant buys and sells in the third quarter. Falcon Edge Capital Management exited its two largest U.S. long positions in the third quarter, according to

  3. SPACs: Hambro Perks eyes first London SPAC listing under new rules, SPACs churn out restatements, again, to correct accounting, Investment manager's SPAC Investcorp Europe Acquisition I files for a $250m IPO[more]

    Hambro Perks eyes first London SPAC listing under new rules From Bloomberg: U.K. venture capital firm Hambro Perks Ltd. aims to raise 140 million pounds ($187 million) listing a special purpose acquisition company in London, in what could be the market's first major blank-check offerin

  4. Opalesque Exclusive: TRF - the right product at the right time (part 1)[more]

    B. G., Opalesque Geneva: Eurex, an international derivatives exchange and a member of the Deutsche Börse Group, has been churning out its pioneering Total Return Futures (TRF) since 2016. In a

  5. Coinbase co-founder launches biggest VC fund in crypto, Valkyrie launches $100m DeFi hedge fund, Kyle Bass says the big money has been made in bitcoin[more]

    Coinbase co-founder launches biggest VC fund in crypto From the FT: Coinbase co-founder Fred Ehrsam and former Sequoia Capital partner Matt Huang have finished raising $2.5bn this month for Paradigm One, their first venture capital fund. Investors jockeyed to commit money to the fund, allo